Health
Pfizer seeking FDA approval for RSV vaccine
Pfizer is working on an RSV vaccine for newborns and now says it has enough data to seek approval from the FDA.
Top Stories
Trending
- Blackburn says Senate has the votes to confirm Blanche, more evidence on Jack Smith has emerged
- Courts rebuke bureaucrats for shutting down Christian programming over pro-life, anti-tax views
- Education Secretary McMahon asks American universities to outline commitments to ‘national service’
- Newsom asked, and donors gave $347 million. What did they get in return?
- Five outside parties file legal briefs in support of agents Patel fired during broad agency purge